Kelly W. Elliott, RN MS
President & CEO
Ms. Elliott founded Eminence Clinical Research Inc with two goals in mind:
- Bring new technologies to patients through research and new device clearances/approvals and further prove the value of previously cleared/approved technologies, and
- Advance research through providing the skills and support necessary to conduct high-quality physician-initiated studies independent of industry oversight.
Throughout Ms. Elliott’s experience, it has been made very clear that high-quality work and well designed and well-executed studies are the foundation for achieving the results that companies desire in an effort to expand their product portfolios. As a registered nurse in the medical-surgical and open heart ICUs, cardiac catheterization lab, Ms. Elliott’s strong clinical background has enabled Ms. Elliott to design and conduct clinical trials in a large variety of applications.
Ms. Elliott has held executive level positions at multiple medical device companies, successfully designing and executing clinical trial strategies resulting in new device approvals and new indications and dozens of publications in peer-reviewed medical journals.
Chuck Walker
VP, Business Development
As soon as Kelly welcomed Chuck to the ECR team, they quickly consolidated their experience, work ethic, chemistry, and networks to offer a comprehensive approach to clinical trials, medical device development, and management.
We are proud that our persistence and work ethic have paid off to establish a company that transforms ideas into reality to enhance medical performance through technological advancement.
Christine Tjossem, BS
Executive Vice President
Biostatistics and Data Operations
Christine Tjossem has over three decades of practical experience in clinical research for medical devices, pharmaceuticals and diagnostics in biostatistics, database development and electronic data capture (EDC) builds on multiple platforms, data management, and clinical data operations.
Her experience includes clinical study design and implementation, comprehensive statistical analyses to support FDA clearances and approvals, oversight and management of internal processes and external resources (such as clinical event committees, data safety monitoring boards, and core labs), and data analyses for regulatory submissions and manuscript preparation. She is able to effectively communicate complicated issues to any audience.